A detailed history of Financial Perspectives, Inc transactions in Dexcom Inc stock. As of the latest transaction made, Financial Perspectives, Inc holds 408 shares of DXCM stock, worth $26,797. This represents 0.02% of its overall portfolio holdings.

Number of Shares
408
Previous 408 -0.0%
Holding current value
$26,797
Previous $56.6 Million 18.26%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jan 09, 2024

BUY
$67.99 - $132.89 $20,804 - $40,664
306 Added 300.0%
408 $30.4 Million
Q2 2021

Jan 09, 2024

SELL
$80.99 - $107.93 $2.96 Million - $3.95 Million
-36,556 Reduced 99.72%
102 $43.6 Million
Q1 2021

Jan 09, 2024

BUY
$84.79 - $104.74 $3.1 Million - $3.83 Million
36,556 Added 35839.22%
36,658 $102,000
Q4 2020

Jan 09, 2024

BUY
$78.0 - $104.5 $7,956 - $10,659
102 New
102 $37.7 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Financial Perspectives, Inc Portfolio

Follow Financial Perspectives, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Perspectives, Inc with notifications on news.